Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Many antineoplastics are designed to target upregulated genes, but quantifying upregulation in a single patient sample requires an appropriate set of samples for comparison. In cancer, the most ...
Concr CEO Irina Babina and CTO Matthew Griffiths unpack how Bayesian foundation models can excel at uncertainty management to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results